HomeTOP STORIESEagle Pharmaceuticals GAAP EPS of -$3.88, revenue of $37.27M Eagle Pharmaceuticals GAAP EPS of -$3.88, revenue of $37.27M By rogerjudd October 7, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleAsylum hotel provider makes £180m profit despite claims of inedible food and rationed loo paperNext articleArtemis Gold produces 60,985 oz in Q3 as Blackwater Mine exceeds mill capacity latest articles Byrna projects 35%-40% revenue growth for 2025 as AI-driven advertising and retail expansion fuel demand Paramount Skydance Chief sees `lots of options’ for media deals SA analysts weigh in on the current government shutdown Gold, Silver And Platinum Surge: Are These Commodities Too Hot For Investors To Touch? | IBD Here are five top stocks to add to your watchlist today. Keystone Global Financial files for IPO of 1.25M shares explore more Byrna projects 35%-40% revenue growth for 2025 as AI-driven advertising and retail expansion fuel demand Paramount Skydance Chief sees `lots of options’ for media deals SA analysts weigh in on the current government shutdown Gold, Silver And Platinum Surge: Are These Commodities Too Hot For Investors To Touch? | IBD Here are five top stocks to add to your watchlist today. Keystone Global Financial files for IPO of 1.25M shares
